Sonoporation delivery of interleukin-27 gene therapy efficiently reduces prostate tumor cell growth in vivo

Human Gene Therapy

Volumn 22, Issue 12, 2011, Pages 1537-1550

  Zolochevska, Olga ^a   Xia, Xueqing ^b   Williams, B Jill ^c   Ramsay, Alistair ^d   Li, Shulin ^b   Figueiredo, Marxa L ^a,e  

^a University of Texas Medical Branch School of Medicine   (United States)

^b UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

^c Louisiana State University Health Sciences Center at Shreveport   (United States)

^d LOUISIANA STATE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^e LOUISIANA STATE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

INTERLEUKIN 27;

ANIMAL CELL; ARTICLE; CANCER GENE THERAPY; CONTROLLED STUDY; EFFECTOR CELL; GENE EXPRESSION; GENE TARGETING; HUMAN; HUMAN CELL; IMMUNOCOMPETENCE; IN VIVO STUDY; IRRADIATION; MALE; MOUSE; NONHUMAN; PROSTATE ADENOCARCINOMA; PROSTATE CANCER; PROSTATE TUMOR; SOUND RELATED PHENOMENA; TUMOR CELL; TUMOR GROWTH; TUMOR REGRESSION; ULTRASOUND;

ANIMALS; BLOTTING, WESTERN; CELL ADHESION; CELL MOVEMENT; CELL PROLIFERATION; DRUG DELIVERY SYSTEMS; FLOW CYTOMETRY; GENE THERAPY; GENE TRANSFER TECHNIQUES; HUMANS; INTERLEUKIN-17; LUMINESCENCE; MALE; MICE; MICE, INBRED C57BL; PROSTATIC NEOPLASMS; REAL-TIME POLYMERASE CHAIN REACTION; RNA, MESSENGER; TUMOR CELLS, CULTURED; ULTRASONICS;

EID: 81255210767     PISSN: 10430342     EISSN: 15577422     Source Type: Journal    
DOI: 10.1089/hum.2011.076     Document Type: Article

References (42)

1. Aoi, A., Watanabe, Y., Mori, S., et al. (2008). Herpes simplex virus thymidine kinase-mediated suicide gene therapy using nano/microbubbles and ultrasound. Ultrasound Med. Biol. 34, 425-434. (Pubitemid 351625448)
2. Awasthi, A., Carrier, Y., Peron, J.P., et al. (2007). A dominant function for interleukin 27 in generating interleukin 10-producing anti-inflammatory T cells. Nat. Immunol. 8, 1380-1389. (Pubitemid 350131175)
3. Azuma, H., Tomita, N., Sakamoto, T., et al. (2008). Marked regression of liver metastasis by combined therapy of ultrasound-mediated NF jB-decoy transfer and transportal injection of paclitaxel, in mouse. Int. J. Cancer 122, 1645-1656. (Pubitemid 351294976)
4. Baley, P.A., Yoshida, K., Qian, W., et al. (1995). Progression to androgen insensitivity in a novel in vitro mouse model for prostate cancer. J. Steroid Biochem. Mol. Biol. 52, 403-413.
5. Bettelli, E., Carrier, Y., Gao, W., et al. (2006). Reciprocal developmental pathways for the generation of pathogenic effector TH17 and regulatory T cells. Nature 441, 235-238.
6. Deshpande, N., Needles, A., and Willmann, J.K. (2010). Molecular ultrasound imaging: current status and future directions. Clin. Radiol. 65, 567-581.
7. Duvshani-Eshet, M., and Machluf, M. (2005). Therapeutic ultrasound optimization for gene delivery: a key factor achieving nuclear DNA localization. J. Control. Release 108, 513-528. (Pubitemid 41613754)
8. Engel, M.A., and Neurath, M.F. (2010). Anticancer properties of the IL-12 family-focus on colorectal cancer. Curr. Med. Chem. 17, 3303-3308.
9. Escoffre, J.M., Piron, J., Novell, A., and Bouakaz, A. (2011). Doxorubicin delivery into tumor cells with ultrasound and microbubbles. Mol. Pharm. 8, 799-806.
10. Feril, L.B., Jr., Ogawa, R., Tachibana, K., and Kondo, T. (2006). Optimized ultrasound-mediated gene transfection in cancer cells. Cancer Sci. 97, 1111-1114. (Pubitemid 44322562)
11. Figueiredo, M.L., Kim, Y., St. John, M.A., and Wong, D.T. (2005). p12CDK2-AP1 gene therapy strategy inhibits tumor growth in an in vivo mouse model of head and neck cancer. Clin. Cancer Res. 11, 3939-3948. (Pubitemid 40685616)
12. Fitzgerald, D.C., Zhang, G.X., El-Behi, M., et al. (2007). Suppression of autoimmune inflammation of the central nervous system by interleukin 10 secreted by interleukin 27-stimulated T cells. Nat. Immunol. 8, 1372-1379. (Pubitemid 350131174)
13. Freeman, S.M., Ramesh, R., and Marrogi, A.J. (1997). Immune system in suicide-gene therapy. Lancet 349, 2-3. (Pubitemid 27022977)
14. Fujita, T., Teh, B.S., Timme, T.L., et al. (2006). Sustained long-term immune responses after in situ gene therapy combined with radiotherapy and hormonal therapy in prostate cancer patients. Int. J. Radiat. Oncol. Biol. Phys. 65, 84-90.
15. Gallina, G., Dolcetti, L., Serafini, P., et al. (2006). Tumors induce a subset of inflammatory monocytes with immunosuppressive activity on CD8 + T cells. J. Clin. Invest. 116, 2777-2790. (Pubitemid 44511641)
16. Ghiringhelli, F., Ménard, C., Terme, M., et al. (2005). CD4+ CD25+ regulatory T cells inhibit natural killer cell functions in a transforming growth factor-b-dependent manner. J. Exp. Med. 202, 1075-1085. (Pubitemid 41464501)
17. Hauff, P., Seemann, S., Reszka, R., et al. (2005). Evaluation of gas-filled microparticles and sonoporation as gene delivery system: feasibility study in rodent tumor models. Radiology 236, 572-578. (Pubitemid 41023442)
18. Huber, M., Steinwald, V., Guralnik, A., et al. (2008). IL-27 inhibits the development of regulatory T cells via STAT3. Int. Immunol. 20, 223-234. (Pubitemid 351234390)
19. Hwang, K.S., Cho, W.K., Yoo, J., et al. (2005). Adenovirus-mediated interleukin-12 gene transfer combined with cytosine deaminase followed by 5-fluorocytosine treatment exerts potent antitumor activity in Renca tumor-bearing mice. BMC Cancer 5, 51.
20. Lentacker, I., De Smedt, S.C., and Sanders, N.N. (2009). Drug loaded microbubble design for ultrasound triggered delivery. Soft Matter 5, 2161-2170.
21. Li, Y.S., Davidson, E., Reid, C.N., and McHale, A.P. (2009). Optimising ultrasound-mediated gene transfer (sonoporation) in vitro and prolonged expression of a transgene in vivo: potential applications for gene therapy of cancer. Cancer Lett. 273, 62-69.
22. Lucas, S., Ghilardi, N., Li, J., and de Sauvage, F.J. (2003). IL-27 regulates IL-12 responsiveness of näve CD4+ T cells through Stat1-dependent and-independent mechanisms. Proc. Natl. Acad. Sci. U.S.A. 100, 15047-15052. (Pubitemid 37518014)
23. Nakamori, M., Iwahashi, M., Ueda, K., et al. (2002). Dose of adenoviral vectors expressing interleukin-2 plays an important role in combined gene therapy with cytosine deaminase/5-fluorocytosine: preclinical consideration. Jpn. J. Cancer Res. 93, 706-715. (Pubitemid 34846279)
24. Neufert, C., Becker, C., Wirtz, S., et al. (2007). IL-27 controls the development of inducible regulatory T cells and Th17 cells via differential effects on STAT1. Eur. J. Immunol. 37, 1809-1816. (Pubitemid 47065120)
25. Newman, C.M., and Bettinger, T. (2007). Gene therapy progress and prospects: ultrasound for gene transfer. Gene Ther. 14, 465-475. (Pubitemid 46390919)
26. Passineau, M.J., Zourelias, L., Machen, L., et al. (2010). Ultrasound-assisted non-viral gene transfer to the salivary glands. Gene Ther. 17, 1318-1324; erratum 18, 424.
27. Pflanz, S., Timans, J.C., Cheung, J., et al. (2002). IL-27, a hetero-dimeric cytokine composed of EBI3 and p28 protein, induces proliferation of naive CD4+ T cells. Immunity 16, 779-790. (Pubitemid 34786477)
28. Phillips, L.C., Klibanov, A.L., Wamhoff, B.R., and Hossack, J.A. (2010). Targeted gene transfection from microbubbles into vascular smooth muscle cells using focused, ultrasound-mediated delivery. Ultrasound Med. Biol. 36, 1470-1480.
29. Pislaru, S.V., Pislaru, C., Kinnick, R.R., et al. (2003). Optimization of ultrasound-mediated gene transfer: comparison of contrast agents and ultrasound modalities. Eur. Heart J. 24, 1690-1698. (Pubitemid 37174910)
30. Sakakima, Y., Hayashi, S., Yagi, Y., et al. (2005). Gene therapy for hepatocellular carcinoma using sonoporation enhanced by contrast agents. Cancer Gene Ther. 12, 884-889. (Pubitemid 41487029)
31. Salcedo, R., Stauffer, J.K., Lincoln, E., et al. (2004). IL-27 mediates complete regression of orthotopic primary and metastatic murine neuroblastoma tumors: role for CD8+ T cells. J. Immunol. 173, 7170-7182. (Pubitemid 39628152)
32. Stride, E.P., and Coussios, C.C. (2010). Cavitation and contrast: the use of bubbles in ultrasound imaging and therapy. Proc. Inst. Mech. Eng. H. 224, 171-191.
33. Suzuki, R., Oda, Y., Namai, E., et al. (2008). [Development of site specific gene delivery system with sonoporation]. Yakugaku Zasshi 128, 187-192. (Pubitemid 351237891)
34. Suzuki, R., Namai, E., Oda, Y., et al. (2010). Cancer gene therapy by IL-12 gene delivery using liposomal bubbles and tumoral ultrasound exposure. J. Control. Release. 142, 245-250.
35. Takeda, A., Hamano, S., Yamanaka, A., et al. (2003). Cutting edge: role of IL-27/WSX-1 signaling for induction of T-bet through activation of STAT1 during initial Th1 commitment. J. Immunol. 170, 4886-4890. (Pubitemid 36554716)
36. Thompson, T.C., Southgate, J., Kitchener, G., and Land, H. (1989). Multistage carcinogenesis induced by ras and myc on-cogenes in a reconstituted organ. Cell 56, 917-930. (Pubitemid 19091004)
37. Toda, M., Martuza, R.L., and Rabkin, S.D. (2001). Combination suicide/cytokine gene therapy as adjuvants to a defective herpes simplex virus-based cancer vaccine. Gene Ther. 8, 332-339. (Pubitemid 32237067)
38. Tsai, K.C., Liao, Z.K., Yang, S.J., et al. (2009). Differences in gene expression between sonoporation in tumor and in muscle. J. Gene Med. 11, 933-940.
39. Wells, D.J. (2010). Electroporation and ultrasound enhanced non-viral gene delivery in vitro and in vivo. Cell Biol. Toxicol. 26, 21-28.
40. Wu, Z., McRoberts, K.S., and Theodorescu, D. (2007). The role of PTEN in prostate cancer cell tropism to the bone micro-environment. Carcinogenesis 28, 1393-1400. (Pubitemid 47241787)
41. Zhu, S., Lee, D.A., and Li, S. (2010). IL-12 and IL-27 sequential gene therapy via intramuscular electroporation delivery for eliminating distal aggressive tumors. J. Immunol. 184, 2348-2354.
42. Zolochevska, O., and Figueiredo, M.L. (2011). Cell-cycle regulators cdk2ap1 and bicalutamide suppress malignant biological interactions between prostate cancer and bone cells. Prostate 71, 353-367.